Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With ¹⁷⁷Lu-Dotatate in the Phase III NETTER-1 Trial

Jonathan Strosberg, Matthew H. Kulke, Edward M. Wolin et al.|Journal of Clinical Oncology|2018

Cited by 388